Stop codon readthrough as a treatment option for epidermolysis bullosa—Where we are and where we are going

Documenti analoghi

• Repurposing diacerein for the treatment of chronic wounds in recessive‐dystrophic epidermolysis bullosa patients by modulating matrix metalloproteinase‐9 expression
  di: Sonja Dorfer, et al.
  Pubblicazione: (2025)
• Granzyme B inhibition reduces autoantibody‐induced dermal–epidermal separation in an ex vivo model of epidermolysis bullosa acquisita
  di: Shirin Emtenani, et al.
  Pubblicazione: (2024)
• Patients suffering from dystrophic epidermolysis bullosa are prone to developing autoantibodies against skin proteins: A longitudinal confirmational study
  di: J. Bremer, et al.
  Pubblicazione: (2024)
• Scarring alopecia and nail loss in a patient with epidermolysis bullosa acquisita
  di: Misaki Kusano, et al.
  Pubblicazione: (2024)
• Sunscreens—Where are we now?
  di: David X. Gao, et al.
  Pubblicazione: (2024)